NYSE · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · SMALL CAP
Myomo, Inc. MYO
10 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$40.9M
▲ 25.7% vs FY2024
EPS · FY25
$-0.37
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-86.2%
Net margin · FY25
-38.1%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 40.9M
Revenue, FY2025 · full 10-year series below
Revenue
Net income
The company lost 38 cents on every revenue dollar this year.
Per share
USD -0.37
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-86.2%
Return on equity, FY2025
ROE
Operating margin-35.2%
Net margin-38.1%
Return on assets-38.5%
Each USD of equity lost 86 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+40.1% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+38.1%
+40.1%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.04B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 38.6M
total assets, end of FY2025
Total assetsUSD 38.6M
EquityUSD 11.4M
CashUSD 14.1M
Gross debtUSD 14.2M
Net debtUSD 44,985.00
Current ratio3.30×
Net debt stands at 0% of equity.
History
10 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
·
·
·
0.0
0.0
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−0.37
−0.16
−0.28
−1.52
−1.89
−3.67
−20.79
−25.18
−2.93
−4.13
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
ROE %
−86.2
−36.7
−106.2
−98.5
−76.9
−128.6
−166.7
−109.3
·
·
Shares out B
0.04
0.03
0.03
0.01
0.01
0.00
0.00
0.00
0.01
0.00
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
40 of 40
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed